Tg Therapeutics (TGTX) Profit After Tax (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Profit After Tax of $19.8 million for Q1 2026, up 290.85% year-over-year from $5.1 million in Q1 2025, and down 14.15% quarter-over-quarter from $23.0 million in Q4 2025.
Tg Therapeutics (TGTX) Profit After Tax (2011 - 2026) Analysis & Trends
Tg Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at $19.8 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 290.85% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $461.9 million (up 1079.81% YoY), while the FY2025 annual figure was $447.2 million, up 1812.41% from the prior year.
- Profit After Tax for Q1 2026 stood at $19.8 million, down from $23.0 million in the prior quarter.
- The five-year high for Profit After Tax was $390.9 million in Q3 2025, with the low at -$78.5 million in Q4 2022.
- The 5-year median for Profit After Tax is $3.9 million (2024), against an average of $16.4 million.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax plunged 96.59% in 2024, then surged 9974.61% in 2025.
- Tg Therapeutics' Profit After Tax stood at -$78.5 million in 2022, then jumped by 81.63% to -$14.4 million in 2023, then surged by 261.84% to $23.3 million in 2024, then fell by 1.26% to $23.0 million in 2025, then slipped by 14.15% to $19.8 million in 2026.
- Business Quant data shows TGTX's Profit After Tax at $19.8 million in Q1 2026, $23.0 million in Q4 2025, and $390.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 7.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.78 Mn |
| Mar 31, 2026 | 19.78 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 390.90 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Dec 31, 2023 | -14.42 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | -47.61 Mn |
| Mar 31, 2023 | -39.23 Mn |
| Dec 31, 2022 | -78.47 Mn |
| Sep 30, 2022 | -35.82 Mn |
| Jun 30, 2022 | -40.51 Mn |
| Mar 31, 2022 | -69.01 Mn |
| Dec 31, 2021 | -93.34 Mn |
| Sep 30, 2021 | -85.64 Mn |